Computational Drug Discovery
AI-driven computational models and algorithms assist in the design of novel drugs. These methods can predict the binding affinity and activity of compounds against a target. AI enhances High-Throughput Screening (HTS) by improving the analysis of large-scale experimental data.
Research And Development
Clearsynth is a strategic outsourcing partner with expertise and experience to fulfill the needs of your goals. We offer comprehensive and distinctive quality services to the pharmaceutical industry and Institutions based on our experience in the field of Drug Discovery and Pharmaceuticals.
Drug Development
Drug development involves
large-scale and commercial
production (GMP and non-GMP) of
drug molecules.
This phase includes animal
toxicology studies and clinical
studies, regulatory submissions,
and NDA submission
-
Strict Quality Practices
-
State of the Art Equipments
-
Customized Solutions
Heart of Innovation and Precision
A space meticulously designed to inspire groundbreaking discoveries and elevate the boundaries of possibility.
-
5 Floors - Curated with Cutting-Edge Equipments
-
350+ Scientists and Support Staff
-
50,000 Sq.ft. + Facility
We drive scientific progress by shaping tomorrow's discoveries, empowering researchers to explore uncharted territories and make groundbreaking advancements
Navigating the Drug Discovery Journey
Driving Innovation in Drug Discovery
Embark on a journey through the intricate process of drug discovery, where science meets innovation to address unmet medical needs. From identifying promising targets to bringing life-saving medications to market, explore the five essential stages that pave the way for groundbreaking therapies.
-
Fastest Turn-around
-
Expert Guidance
-
End-to-End Documentation
Target Identification
This stage involves identifying a biological target (such as a protein or enzyme) that plays a key role in a disease process. The target must be validated to ensure that modulating it could lead to a therapeutic effect.
Hit Discovery and Lead Optimization
In this stage, potential drug compounds (hits) are identified through various methods, such as high-throughput screening or computational approaches. These hits are then optimized to improve their potency, selectivity, and other properties.
Preclinical Research
Once lead compounds are identified, they undergo preclinical research to assess their safety, efficacy, pharmacokinetics, and pharmacodynamics in laboratory and animal studies.
Clinical Development
This stage involves testing the drug candidate in human clinical trials to evaluate its safety and efficacy consisting of three phases: Phase 1 (safety and dosing), Phase 2 (efficacy and side effects), and Phase 3 (large-scale efficacy).
Regulatory Approval and Market Launch
In this final stage, the drug candidate that has successfully completed clinical trials is submitted to regulatory agencies for approval. If approved, the drug is launched into the market, where it becomes available for prescription and use by patients.
Target Identification
This stage involves identifying a biological target (such as a protein or enzyme) that plays a key role in a disease process. The target must be validated to ensure that modulating it could lead to a therapeutic effect.
Hit Discovery and Lead Optimization
In this stage, potential drug compounds (hits) are identified through various methods, such as high-throughput screening or computational approaches. These hits are then optimized to improve their potency, selectivity, and other properties.
Preclinical Research
Once lead compounds are identified, they undergo preclinical research to assess their safety, efficacy, pharmacokinetics, and pharmacodynamics in laboratory and animal studies.
Clinical Development
This stage involves testing the drug candidate in human clinical trials to evaluate its safety and efficacy consisting of three phases: Phase 1 (safety and dosing), Phase 2 (efficacy and side effects), and Phase 3 (large-scale efficacy).
Regulatory Approval and Market Launch
In this final stage, the drug candidate that has successfully completed clinical trials is submitted to regulatory agencies for approval. If approved, the drug is launched into the market, where it becomes available for prescription and use by patients.
Technology & resources
Delve into the cutting-edge technologies and platforms driving our drug discovery initiatives forward. From artificial intelligence and machine learning to high-throughput screening and structural biology, learn how we harness the power of innovation to unlock new opportunities and overcome complex scientific challenges